EMA - New features further strengthen PRIority Medicines scheme (PRIME)

12th April 2023

EMA

EMA is introducing a number of new features to the PRIority Medicines (PRIME) scheme to strengthen its support for the development of medicines in areas of unmet medical needs. The PRIME scheme enables earlier availability of life-changing medicines for patients. By the end of 2022, 26 medicines that benefited from PRIME support had received a positive recommendation for approval in the European Union (EU). 

Read More

Back to News Archive